| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CHRO | Channel Therapeutics Corp | CFO, Treas & Secty | $114K | Jul 2, 2025 | ||
| BLNE | Beeline Holdings, Inc. | Director | $96.8K | Oct 2, 2025 | ||
| ATNF, ATNFW | 180 Life Sciences Corp. | Director | Sep 4, 2023 | |||
| IVBT | Innovation1 Biotech Inc. | Chairman and Interim CEO, Director | Nov 1, 2024 | |||
| CDT, CDTTW | CONDUIT PHARMACEUTICALS INC. | Director | Feb 2, 2022 | |||
| OTEC | OceanTech Acquisitions I Corp. | Chief Financial Officer | Mar 13, 2023 | |||
| RACY | Relativity Acquisition Corp | Director | Feb 10, 2022 | |||
| TVGN, TVGNW | Tevogen Bio Holdings Inc. | Chief Financial Officer | Jun 7, 2023 | |||
| UNRV | Unrivaled Brands, Inc. | CEO and President, Director | Jun 18, 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|